Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- Check2 days agoChange DetectedThe page now shows an 'Last Update Posted (Estimated)' label and updated date fields (including 2025-12 and 2029-12), with some previous timestamp entries removed; this affects how update recency is displayed but not the substantive study information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now lists study locations across multiple US states and international sites, and shows Revision: v3.3.3. This update informs where to enroll and whom to contact at each site.SummaryDifference1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedPublications section wording updated to say entries are automatically filled from PubMed. The page now shows a new Revision: v3.3.2 label.SummaryDifference0.0%

- Check52 days agoChange DetectedThe Notice About Lapse in Government Funding has been removed from the page. Previously, the notice warned that information may not be up to date due to funding status and provided operating status details.SummaryDifference0.2%

- Check66 days agoChange DetectedNo additions or deletions were detected in the page content. Core study information, eligibility criteria, outcomes, and locations appear unchanged.SummaryDifference0.2%

- Check95 days agoChange DetectedThe page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old v3.1.0.SummaryDifference0.7%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.